ABOS

Acumen Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 0/10
  • Momentum↑ 9/10
Acumen Pharmaceuticals sales and earnings growth
ABOS Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -60.87%
  • FCF Y/Y↓ -83.75%
Acumen Pharmaceuticals gross and profit margin trends
ABOS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -81.60%
Acumen Pharmaceuticals net debt vs free cash flow
ABOS Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -30.9

Acumen Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗